Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
35,412,137
-
Share change
-
+443,261
-
Total reported value
-
$292,557,777
-
Put/Call ratio
-
67867%
-
Price per share
-
$8.29
-
Number of holders
-
112
-
Value change
-
+$6,899,463
-
Number of buys
-
61
-
Number of sells
-
50
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q3 2024
As of 30 Sep 2024,
Pulmonx Corp - COM (LUNG) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,412,137 shares.
The largest 10 holders included
FMR LLC, PRIMECAP MANAGEMENT CO/CA/, MORGAN STANLEY, BlackRock, Inc., VANGUARD GROUP INC, DEUTSCHE BANK AG\, BNP PARIBAS ASSET MANAGEMENT Holding S.A., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and BRAIDWELL LP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.